The shares of Force Motors were trading in the green on Wednesday after the company announced robust sales number for January 2020.

The expansion was expected to be over by December 2019 which was extended till January 2020. Delay in the recommencement of plant resulted in a sharp decline in the stock price.

The market opened in the green on February 5, 2020, overall volumes in futures & options currently stand at 2.29 crore contracts with a turnover of Rs. 16,47,159.52 crore.

The market opened in the green on February 5, 2020, overall volumes in futures & options currently stand at 2.29 crore contracts with a turnover of Rs. 16,47,159.52 crore.

The market opened in the green on February 5, 2020. The previous trading session witnessed the Sensex going up by 917.07 points to end at 40,789.38 and the Nifty was up by 271.75 points to close at 11,979.65.

The market opened in the green on February 5, 2020. The previous trading session witnessed the Sensex going up by 917.07 points to end at 40,789.38 and the Nifty was up by 271.75 points to close at 11,979.65.

Granules India on Wednesday said that Granules Pharmaceuticals, a wholly-owned foreign subsidiary of Granules India Limited, has received an approval from US Food & Drug Administration (USFDA) for Oral Solution 50 mg/ml of Valganciclovir Hydrochloride, which is bioequivalent to Reference Listed Drug (RLD) Valcyte for Oral Solution 50 mg/ml of Roche Palo Alto LLC.

Cadila Healthcare gained 2.33 per cent today after the company informed that United States Food and Drug Administration (USFDA) has successfully completed the inspection at its manufacturing facility in Ahmedabad with no observations.

The Budget Day high of 12,017 is likely to act as an immediate resistance for the index. Moving past this resistance zone is likely to help bulls reclaim its 20-DMA which currently stands at 12,140. On the downside, a support is seen at the opening upside gap area (11,783-11,750). Stocks in news: Reliance Industries, Cadila Healthcare, Teamlease Services, BEML, Sun Pharmaceutical.

With the gains posted in the last two trading sessions, markets returned to almost pre-Budget level, helped by buying across the board as nerves calmed down after the knee-jerk reaction of the Budget announcements.